Insider Transactions in Q2 2025 at Candel Therapeutics, Inc. (CADL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
781
-1.47%
|
$3,905
$5.04 P/Share
|
|
Jun 30
2025
|
William Garrett Nichols Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
781
+1.44%
|
$781
$1.29 P/Share
|
|
Jun 25
2025
|
Joseph C Papa |
BUY
Grant, award, or other acquisition
|
Indirect |
64,239
+50.0%
|
$256,956
$4.67 P/Share
|
|
Jun 25
2025
|
Francesca Barone Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,282
+4.07%
|
$17,128
$4.67 P/Share
|
|
Jun 25
2025
|
Gary J. Nabel |
BUY
Grant, award, or other acquisition
|
Direct |
5,353
+50.0%
|
$21,412
$4.67 P/Share
|
|
Jun 25
2025
|
Nicoletta Loggia |
BUY
Grant, award, or other acquisition
|
Direct |
2,141
+50.0%
|
$8,564
$4.67 P/Share
|
|
Jun 25
2025
|
Charles Schoch Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,353
+10.98%
|
$21,412
$4.67 P/Share
|
|
Jun 25
2025
|
Christopher Martell |
BUY
Grant, award, or other acquisition
|
Indirect |
111,349
+50.0%
|
$445,396
$4.67 P/Share
|
|
Jun 25
2025
|
Paul B Manning |
BUY
Grant, award, or other acquisition
|
Indirect |
1,070,663
+32.61%
|
$4,282,652
$4.67 P/Share
|
|
Jun 25
2025
|
Paul Peter Tak Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,826
+13.75%
|
$171,304
$4.67 P/Share
|
|
Jun 25
2025
|
Seshu Tyagarajan Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,353
+5.56%
|
$21,412
$4.67 P/Share
|